Cargando…

GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation

O-GlcNAcylation is an essential, dynamic and inducible post-translational glycosylation of cytosolic proteins in metazoa and can show interplay with protein phosphorylation. Inhibition of OGA (O-GlcNAcase), the enzyme that removes O-GlcNAc from O-GlcNAcylated proteins, is a useful strategy to probe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorfmueller, Helge C., Borodkin, Vladimir S., Schimpl, Marianne, van Aalten, Daan M. F.
Formato: Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691177/
https://www.ncbi.nlm.nih.gov/pubmed/19275764
http://dx.doi.org/10.1042/BJ20090110
_version_ 1782167867961114624
author Dorfmueller, Helge C.
Borodkin, Vladimir S.
Schimpl, Marianne
van Aalten, Daan M. F.
author_facet Dorfmueller, Helge C.
Borodkin, Vladimir S.
Schimpl, Marianne
van Aalten, Daan M. F.
author_sort Dorfmueller, Helge C.
collection PubMed
description O-GlcNAcylation is an essential, dynamic and inducible post-translational glycosylation of cytosolic proteins in metazoa and can show interplay with protein phosphorylation. Inhibition of OGA (O-GlcNAcase), the enzyme that removes O-GlcNAc from O-GlcNAcylated proteins, is a useful strategy to probe the role of this modification in a range of cellular processes. In the present study, we report the rational design and evaluation of GlcNAcstatins, a family of potent, competitive and selective inhibitors of human OGA. Kinetic experiments with recombinant human OGA reveal that the GlcNAcstatins are the most potent human OGA inhibitors reported to date, inhibiting the enzyme in the sub-nanomolar to nanomolar range. Modification of the GlcNAcstatin N-acetyl group leads to up to 160-fold selectivity against the human lysosomal hexosaminidases which employ a similar substrate-assisted catalytic mechanism. Mutagenesis studies in a bacterial OGA, guided by the structure of a GlcNAcstatin complex, provides insight into the role of conserved residues in the human OGA active site. GlcNAcstatins are cell-permeant and, at low nanomolar concentrations, effectively modulate intracellular O-GlcNAc levels through inhibition of OGA, in a range of human cell lines. Thus these compounds are potent selective tools to study the cell biology of O-GlcNAc.
format Text
id pubmed-2691177
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-26911772009-06-04 GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation Dorfmueller, Helge C. Borodkin, Vladimir S. Schimpl, Marianne van Aalten, Daan M. F. Biochem J Research Article O-GlcNAcylation is an essential, dynamic and inducible post-translational glycosylation of cytosolic proteins in metazoa and can show interplay with protein phosphorylation. Inhibition of OGA (O-GlcNAcase), the enzyme that removes O-GlcNAc from O-GlcNAcylated proteins, is a useful strategy to probe the role of this modification in a range of cellular processes. In the present study, we report the rational design and evaluation of GlcNAcstatins, a family of potent, competitive and selective inhibitors of human OGA. Kinetic experiments with recombinant human OGA reveal that the GlcNAcstatins are the most potent human OGA inhibitors reported to date, inhibiting the enzyme in the sub-nanomolar to nanomolar range. Modification of the GlcNAcstatin N-acetyl group leads to up to 160-fold selectivity against the human lysosomal hexosaminidases which employ a similar substrate-assisted catalytic mechanism. Mutagenesis studies in a bacterial OGA, guided by the structure of a GlcNAcstatin complex, provides insight into the role of conserved residues in the human OGA active site. GlcNAcstatins are cell-permeant and, at low nanomolar concentrations, effectively modulate intracellular O-GlcNAc levels through inhibition of OGA, in a range of human cell lines. Thus these compounds are potent selective tools to study the cell biology of O-GlcNAc. Portland Press Ltd. 2009-05-13 2009-06-01 /pmc/articles/PMC2691177/ /pubmed/19275764 http://dx.doi.org/10.1042/BJ20090110 Text en © 2009 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by-nc/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dorfmueller, Helge C.
Borodkin, Vladimir S.
Schimpl, Marianne
van Aalten, Daan M. F.
GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
title GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
title_full GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
title_fullStr GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
title_full_unstemmed GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
title_short GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
title_sort glcnacstatins are nanomolar inhibitors of human o-glcnacase inducing cellular hyper-o-glcnacylation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691177/
https://www.ncbi.nlm.nih.gov/pubmed/19275764
http://dx.doi.org/10.1042/BJ20090110
work_keys_str_mv AT dorfmuellerhelgec glcnacstatinsarenanomolarinhibitorsofhumanoglcnacaseinducingcellularhyperoglcnacylation
AT borodkinvladimirs glcnacstatinsarenanomolarinhibitorsofhumanoglcnacaseinducingcellularhyperoglcnacylation
AT schimplmarianne glcnacstatinsarenanomolarinhibitorsofhumanoglcnacaseinducingcellularhyperoglcnacylation
AT vanaaltendaanmf glcnacstatinsarenanomolarinhibitorsofhumanoglcnacaseinducingcellularhyperoglcnacylation